BB Biotech - Positive trial news lifts two portfolio holdings
In our last BB Biotech (BION) review note, published in May 2024, we noted that the biotech sector was eagerly awaiting some key milestones, the...
224 Views
BB Biotech - A recovering sector with a healthy prognosis
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. It is the largest biotech investor among its...
195 Views
BB Biotech - A cutting-edge sector and a high dividend
BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. BION is the largest biotech investor among its...
237 Views
BB Biotech - Picking growth at good value
According to BB Biotech’s (BION’s) investment team, the biotech industry remains in a very good position. Following a sell-off in the last two...
287 Views
BB Biotech - Great valuation potential
According to BB Biotech’s (BION) investment team, the biotech industry has never looked in such a good position. Following a sell-off in the last...
668 Views